Literature DB >> 23456305

Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND.

Peter J Gaskill1, Tina M Calderon, Jacqueline S Coley, Joan W Berman.   

Abstract

Central nervous system (CNS) complications resulting from HIV infection remain a major public health problem as individuals live longer due to the success of combined antiretroviral therapy (cART). As many as 70 % of HIV infected people have HIV associated neurocognitive disorders (HAND). Many HIV infected individuals abuse drugs, such as cocaine, heroin or methamphetamine, that may be important cofactors in the development of HIV CNS disease. Despite different mechanisms of action, all drugs of abuse increase extracellular dopamine in the CNS. The effects of dopamine on HIV neuropathogenesis are not well understood, and drug induced increases in CNS dopamine may be a common mechanism by which different types of drugs of abuse impact the development of HAND. Monocytes and macrophages are central to HIV infection of the CNS and to HAND. While T cells have not been shown to be a major factor in HIV-associated neuropathogenesis, studies indicate that T cells may play a larger role in the development of HAND in HIV infected drug abusers. Drug induced increases in CNS dopamine may dysregulate functions of, or increase HIV infection in, monocytes, macrophages and T cells in the brain. Thus, characterizing the effects of dopamine on these cells is important for understanding the mechanisms that mediate the development of HAND in drug abusers.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23456305      PMCID: PMC4303241          DOI: 10.1007/s11481-013-9443-y

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  250 in total

1.  Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs.

Authors:  S Czub; E Koutsilieri; S Sopper; M Czub; C Stahl-Hennig; J G Müller; V Pedersen; W Gsell; J L Heeney; M Gerlach; G Gosztonyi; P Riederer; V ter Meulen
Journal:  Acta Neuropathol       Date:  2001-02       Impact factor: 17.088

Review 2.  Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transport.

Authors:  Italo Mocchetti; Alessia Bachis; Valeriya Avdoshina
Journal:  Neurotox Res       Date:  2011-09-27       Impact factor: 3.911

Review 3.  HIV-associated opportunistic infections of the CNS.

Authors:  Ik Lin Tan; Bryan R Smith; Gloria von Geldern; Farrah J Mateen; Justin C McArthur
Journal:  Lancet Neurol       Date:  2012-07       Impact factor: 44.182

Review 4.  A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection.

Authors:  Stephanie D Kraft-Terry; Shilpa J Buch; Howard S Fox; Howard E Gendelman
Journal:  Neuron       Date:  2009-10-15       Impact factor: 17.173

Review 5.  Mechanisms of macrophage antimicrobial activity.

Authors:  C F Nathan
Journal:  Trans R Soc Trop Med Hyg       Date:  1983       Impact factor: 2.184

6.  IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.

Authors:  Yutaka Komiyama; Susumu Nakae; Taizo Matsuki; Aya Nambu; Harumichi Ishigame; Shigeru Kakuta; Katsuko Sudo; Yoichiro Iwakura
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

7.  Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence.

Authors:  Christina S Meade; Nina A Conn; Linda M Skalski; Steven A Safren
Journal:  J Behav Med       Date:  2010-09-21

8.  fMRI brain activation during a delay discounting task in HIV-positive adults with and without cocaine dependence.

Authors:  Christina S Meade; Steven B Lowen; Robert R MacLean; Mary D Key; Scott E Lukas
Journal:  Psychiatry Res       Date:  2011-05-04       Impact factor: 3.222

9.  Immune reconstitution inflammatory syndrome in a large multicenter cohort study: case definition and comparability.

Authors:  Graeme Meintjes; Andrew Boulle
Journal:  Expert Rev Anti Infect Ther       Date:  2012-07       Impact factor: 5.091

10.  Divergent effects of norepinephrine, dopamine and substance P on the activation, differentiation and effector functions of human cytotoxic T lymphocytes.

Authors:  Carina Strell; Anne Sievers; Philipp Bastian; Kerstin Lang; Bernd Niggemann; Kurt S Zänker; Frank Entschladen
Journal:  BMC Immunol       Date:  2009-12-08       Impact factor: 3.615

View more
  38 in total

1.  Role of Macrophage Dopamine Receptors in Mediating Cytokine Production: Implications for Neuroinflammation in the Context of HIV-Associated Neurocognitive Disorders.

Authors:  R A Nolan; R Muir; K Runner; E K Haddad; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2018-12-05       Impact factor: 4.147

2.  The role of catecholamines in HIV neuropathogenesis.

Authors:  R Nolan; P J Gaskill
Journal:  Brain Res       Date:  2018-04-27       Impact factor: 3.252

Review 3.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

Review 4.  Chronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistence.

Authors:  Alexander J Gill; Dennis L Kolson
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

Review 5.  Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults.

Authors:  Stephanie M Matt; Peter J Gaskill
Journal:  Brain Res       Date:  2019-08-21       Impact factor: 3.252

Review 6.  Effects of HIV and Methamphetamine on Brain and Behavior: Evidence from Human Studies and Animal Models.

Authors:  Virawudh Soontornniyomkij; James P Kesby; Erin E Morgan; Amanda Bischoff-Grethe; Arpi Minassian; Gregory G Brown; Igor Grant
Journal:  J Neuroimmune Pharmacol       Date:  2016-08-02       Impact factor: 4.147

7.  Dopamine increases HIV entry into macrophages by increasing calcium release via an alternative signaling pathway.

Authors:  E A Nickoloff-Bybel; P Mackie; K Runner; S M Matt; H Khoshbouei; P J Gaskill
Journal:  Brain Behav Immun       Date:  2019-08-27       Impact factor: 7.217

Review 8.  The Complex Interaction Between Methamphetamine Abuse and HIV-1 Pathogenesis.

Authors:  Ryan Colby Passaro; Jui Pandhare; Han-Zhu Qian; Chandravanu Dash
Journal:  J Neuroimmune Pharmacol       Date:  2015-04-08       Impact factor: 4.147

9.  Age-Related Decrease in Tyrosine Hydroxylase Immunoreactivity in the Substantia Nigra and Region-Specific Changes in Microglia Morphology in HIV-1 Tg Rats.

Authors:  David R Goulding; Andrew Kraft; Peter R Mouton; Christopher A McPherson; Valeria Avdoshina; Italo Mocchetti; G Jean Harry
Journal:  Neurotox Res       Date:  2019-07-08       Impact factor: 3.911

Review 10.  The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease.

Authors:  Phillip Mackie; Joe Lebowitz; Leila Saadatpour; Emily Nickoloff; Peter Gaskill; Habibeh Khoshbouei
Journal:  Brain Behav Immun       Date:  2018-03-15       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.